Biography and Research Information
OverviewAI-generated summary
Marina Avram's research focuses on the development and validation of analytical technologies for forensic investigations and the study of drug effects in preclinical models. Her work includes the validation of hands-free analytical urine testing technology for drug-facilitated crime investigations and the development of ToxBox kits that automate LC-MS/MS analyses to identify emerging drug threats. Avram also investigates the pharmacological effects of novel synthetic opioids and cannabinoids in mice, examining their impact on antinociception, dependence, withdrawal, and their interaction with fentanyl-induced respiratory depression. She has published four papers, with a recent publication in 2026. Avram collaborates with several researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi and Jeffery H. Moran, with whom she shares multiple publications.
Metrics
- h-index: 3
- Publications: 5
- Citations: 10
Selected Publications
-
Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses (2026)
-
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)
-
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice (2025)
-
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)
Collaboration Network
Top Collaborators
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Similar Researchers
Based on overlapping research topics